TMPRSS2:ERG
- Aliases
-
- T2:ERG
- T2S:ERG
- TMPRSS2:ERG
- Description
- TMPRSS2:ERG gene fusions are a common genetic event in prostate cancer. These fusions are specific for prostate cancer and have also been observed in precursor lesions. Since TMPRSS2:ERG fusions are not seen in every prostate cancer, their utility is in assays combined with other biomarkers, such as PCA3.
Attributes
- QA State
- Curated
- Type
- Gene
- HGNC Name
- Certifications
- QA State for Prostate
- Curated
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
- A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.
- Beyond PSA: the next generation of prostate cancer biomarkers.
- Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.
- Correlation of urine TMPRSS2:ERG and PCA3 to ERG+ and total prostate cancer burden.
- Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.
- Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.